|[January 23, 2013]
IYIA Technologies Announces New Treatment Option for Foot Ulcers and Other Wounds That Won't Heal
SAN MARCOS, Calif. --(Business Wire)--
Seven years in development, the FDA cleared-to-market O²Misly™ Wound
Treatment System is now available to the public. The system, developed
by San Diego inventor Adrian Pelkus, uses Vaporous Hyperoxia Therapy, a
newly patented process wherein oxygen is infused with a vapor which
delivers an anti-microbial to the affected area. The anti-microbial mist
stops infections, opens micro capillaries which encourages blood flow
and the oxygen bath then encourages blood vessel growth.
Studies conducted by physicians have shown that the O²Misly is more than
twice as effective as other wound treatment systems. In announcing the
availability of treatments, Adrian Pelkus, founder of IYIA Technologies,
comments "The results todate have been excellent, and that's why we are
offering it on a pay-for-results basis. If a patient's wound is not
healing, they don't pay."
Patients are comfortable during treatment and need not be enclosed in a
pressurized / hospital based hyperbaric chamber as with other systems.
The private-pay therapy takes place one hour twice a week at the
patient's home under the direction of John Qian, MD of the Advanced Pain
and Rehab Center on Ruffin Road in San Diego. Patients with chronic
wound conditions may call 760.752.1036 for information about the
Adrian Pelkus founded IYIA Technologies, located in San Marcos,
California, in April 2004 to develop and market his new wound treatment
device. The company name, IYIA (pronounced eye-EE-yah), is from the
Greek word for health. Pelkus is President and CEO of IYIA Technologies
and is a named inventor on ten issued U.S. Patents. The O²Misly™ Wound
Treatment System is a proprietary, patented device for treating patients
with burns, chronic wounds such as bedsores and slow healing wounds,
primarily diabetic foot ulcers.
[ Back To Technology News's Homepage ]